Biolase, Inc
BIOL
Revenue
11.56M
▲1.42M▲14.06%
3 Months ChangeAssets
30.64M
▼-3.71M▼-10.81%
3 Months ChangeLiabilities
32.77M
▼-1.32M▼-3.86%
3 Months ChangeFree Cash Flow
-5.94M
▲307.00k▲4.92%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-18
Form 8-K
ID: 0000950170-24-074580
2024-05-17
Form 8-K
ID: 0000950170-24-061330
2024-05-13
Form 10-Q
ID: 0000950170-24-058704
2024-05-13
Form 8-K
ID: 0000950170-24-058626
2024-05-06
Form 8-K
ID: 0000950170-24-053536
2024-04-19
Form 8-K
ID: 0000950170-24-046010
2024-03-21
Form 8-K
ID: 0000950170-24-034671
2024-03-05
Form 8-K
ID: 0001193125-24-058505
2024-02-27
Form 8-K
ID: 0001193125-24-047937
2024-02-21
Form 8-K
ID: 0001193125-24-040694